Resorba develops, manufactures and markets surgical suture material and collagen products, focusing on wound closure, haemostasis, antibiotic protection and dental surgery applications.
In 2009, the third generation family-owned enterprise was on the lookout for a succession solution. Contact between the parties came about via Brockhaus Private Equity’s M&A network, and the company was acquired by means of a buy-out in July of that year. With a view to exploiting its potential to the full, the company focused on international expansion with the assistance of Brockhaus Private Equity. It was able to further exploit growth opportunities in the dental market by setting up its own sales team.
Resorba was sold to the Advanced Medical Solutions Group, a leading supplier of wound treatment products listed on the London Stock Exchange at the end of 2011.